Does ADALIMUMAB-RYVK Cause Hospitalisation? 20 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Hospitalisation have been filed in association with ADALIMUMAB-RYVK (Simlandi). This represents 4.3% of all adverse event reports for ADALIMUMAB-RYVK.
20
Reports of Hospitalisation with ADALIMUMAB-RYVK
4.3%
of all ADALIMUMAB-RYVK reports
2
Deaths
20
Hospitalizations
How Dangerous Is Hospitalisation From ADALIMUMAB-RYVK?
Of the 20 reports, 2 (10.0%) resulted in death, 20 (100.0%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB-RYVK. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB-RYVK Cause?
Off label use (70)
Product dose omission issue (67)
Crohn's disease (65)
Inappropriate schedule of product administration (57)
Rheumatoid arthritis (47)
Death (45)
Diarrhoea (43)
Arthralgia (42)
Pain (42)
Fatigue (39)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which ADALIMUMAB-RYVK Alternatives Have Lower Hospitalisation Risk?
ADALIMUMAB-RYVK vs ADALIMUMAB\ISOPROPYL ALCOHOL
ADALIMUMAB-RYVK vs ADAPALENE
ADALIMUMAB-RYVK vs ADAPALENE\BENZOYL PEROXIDE
ADALIMUMAB-RYVK vs ADCETRIS
ADALIMUMAB-RYVK vs ADDERALL